auto-update week 22

middle-east/ir.json

@@ -317,7 +317,7 @@
       "vectorborne diseases": {
         "text": "Crimean-Congo hemorrhagic fever"
       },
-      "note": "<strong>note:</strong> a new coronavirus is causing sustained community spread of respiratory illness (COVID-19) in Iran; sustained community spread means that people have been infected with the virus, but how or where they became infected is not known, and the spread is ongoing; illness with this virus has ranged from mild to severe with fatalities reported; as of 25 April 2021, Iran has reported a total of 2,377,039 cases of COVID-19 or 2,830.0 cumulative cases of COVID-19 per 100,000 population with 82.3 cumulative deaths per 100,000 population; as of 28 April 2021, .9% of the population has received at least one dose of COVID-19 vaccine"
+      "note": "<strong>note:</strong> a new coronavirus is causing sustained community spread of respiratory illness (COVID-19) in Iran; sustained community spread means that people have been infected with the virus, but how or where they became infected is not known, and the spread is ongoing; illness with this virus has ranged from mild to severe with fatalities reported; as of 16 May 2021, Iran has reported a total of 2,739,875 cases of COVID-19 or 3,262.0 cumulative cases of COVID-19 per 100,000 population with 91.2 cumulative deaths per 100,000 population; as of 18 May 2021, 2.36% of the population has received at least one dose of COVID-19 vaccine"
     },
     "Obesity - adult prevalence rate": {
       "text": "25.8% (2016)"
@@ -453,7 +453,7 @@
       "vectorborne diseases": {
         "text": "Crimean-Congo hemorrhagic fever"
       },
-      "note": "<strong>note:</strong> a new coronavirus is causing sustained community spread of respiratory illness (COVID-19) in Iran; sustained community spread means that people have been infected with the virus, but how or where they became infected is not known, and the spread is ongoing; illness with this virus has ranged from mild to severe with fatalities reported; as of 25 April 2021, Iran has reported a total of 2,377,039 cases of COVID-19 or 2,830.0 cumulative cases of COVID-19 per 100,000 population with 82.3 cumulative deaths per 100,000 population; as of 28 April 2021, .9% of the population has received at least one dose of COVID-19 vaccine"
+      "note": "<strong>note:</strong> a new coronavirus is causing sustained community spread of respiratory illness (COVID-19) in Iran; sustained community spread means that people have been infected with the virus, but how or where they became infected is not known, and the spread is ongoing; illness with this virus has ranged from mild to severe with fatalities reported; as of 16 May 2021, Iran has reported a total of 2,739,875 cases of COVID-19 or 3,262.0 cumulative cases of COVID-19 per 100,000 population with 91.2 cumulative deaths per 100,000 population; as of 18 May 2021, 2.36% of the population has received at least one dose of COVID-19 vaccine"
     },
     "Waste and recycling": {
       "municipal solid waste generated annually": {

middle-east/iz.json

@@ -310,7 +310,7 @@
       "food or waterborne diseases": {
         "text": "bacterial diarrhea, hepatitis A, and typhoid fever"
       },
-      "note": "<strong>note:</strong> widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Iraq; as of 25 April 2021, Iraq has reported a total of 1,025,288 cases of COVID-19 or 2,549.0 cumulative cases of COVID-19 per 100,000 population with 37.8 cumulative deaths per 100,000 population; as of 28 April 2021, .7% of the population has received at least one dose of COVID-19 vaccine"
+      "note": "<strong>note:</strong> widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Iraq; as of 16 May 2021, Iraq has reported a total of 1,136,917 cases of COVID-19 or 2,826.6 cumulative cases of COVID-19 per 100,000 population with 39.6 cumulative deaths per 100,000 population; as of 18 May 2021, 1.13% of the population has received at least one dose of COVID-19 vaccine"
     },
     "Obesity - adult prevalence rate": {
       "text": "30.4% (2016)"
@@ -432,7 +432,7 @@
       "food or waterborne diseases": {
         "text": "bacterial diarrhea, hepatitis A, and typhoid fever"
       },
-      "note": "<strong>note:</strong> widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Iraq; as of 25 April 2021, Iraq has reported a total of 1,025,288 cases of COVID-19 or 2,549.0 cumulative cases of COVID-19 per 100,000 population with 37.8 cumulative deaths per 100,000 population; as of 28 April 2021, .7% of the population has received at least one dose of COVID-19 vaccine"
+      "note": "<strong>note:</strong> widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Iraq; as of 16 May 2021, Iraq has reported a total of 1,136,917 cases of COVID-19 or 2,826.6 cumulative cases of COVID-19 per 100,000 population with 39.6 cumulative deaths per 100,000 population; as of 18 May 2021, 1.13% of the population has received at least one dose of COVID-19 vaccine"
     },
     "Food insecurity": {
       "severe localized food insecurity": {

middle-east/tu.json

@@ -309,7 +309,7 @@
       "respiratory diseases": {
         "text": "Covid-19 (2020)"
       },
-      "note": "<strong>note:</strong> widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Turkey; as of 25 April 2021, Turkey has reported a total of 4,591,416 cases of COVID-19 or 5,444.0 cumulative cases of COVID-19 per 100,000 population with 45.1 cumulative deaths per 100,000 population; as of 28 April 2021, 16% of the population has received at least one dose of COVID-19 vaccine"
+      "note": "<strong>note:</strong> widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Turkey; as of 16 May 2021, Turkey has reported a total of 5,106,862 cases of COVID-19 or 6,055.2 cumulative cases of COVID-19 per 100,000 population with 52.8 cumulative deaths per 100,000 population; as of 18 May 2021, 18.03% of the population has received at least one dose of COVID-19 vaccine"
     },
     "Obesity - adult prevalence rate": {
       "text": "32.1% (2016)"
@@ -439,7 +439,7 @@
       "respiratory diseases": {
         "text": "Covid-19 (2020)"
       },
-      "note": "<strong>note:</strong> widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Turkey; as of 25 April 2021, Turkey has reported a total of 4,591,416 cases of COVID-19 or 5,444.0 cumulative cases of COVID-19 per 100,000 population with 45.1 cumulative deaths per 100,000 population; as of 28 April 2021, 16% of the population has received at least one dose of COVID-19 vaccine"
+      "note": "<strong>note:</strong> widespread ongoing transmission of a respiratory illness caused by the novel coronavirus (COVID-19) is occurring throughout Turkey; as of 16 May 2021, Turkey has reported a total of 5,106,862 cases of COVID-19 or 6,055.2 cumulative cases of COVID-19 per 100,000 population with 52.8 cumulative deaths per 100,000 population; as of 18 May 2021, 18.03% of the population has received at least one dose of COVID-19 vaccine"
     },
     "Waste and recycling": {
       "municipal solid waste generated annually": {